Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Roche CEO says new drugs will offset biosimilar incursions

CEO Severin Schwan of Swiss drugmaker Roche addresses the company's annual news conference in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann

ZURICH (Reuters) - Swiss drugmaker Roche will be able to compensate or overcompensate for falling revenue from patent-expired drugs facing competition from rivals' copies through its new medicines, Chief Executive Severin Schwan said on Tuesday.

Schwan's outlook, delivered to shareholders at the company's annual general meeting in Basel, confirms Roche's previous guidance that 2018 sales will be flat or grow by a low-single-digit percentage compared to last year, amid incursions from so-called biosimilar drugs.

(Reporting by John Miller)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.